Prof. Robin Feldman discusses "evergreen" drug pricing, from her paper in the Journal of Law and the Biosciences, which you can read here: https://academic.oup.com/jlb/article/5/3/590/5232981.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Neurology Minute","authorlink":""},"src":"http:\/\/traffic.libsyn.com\/neurologyminute\/August_19_2019_NM_WT_Crowell__Feldman_ver2.mp3?dest-id=1085030","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202109\/c33030-202f-27e9-f6fd80_800.png"},"title":"\"Evergreen\" Drug Prices","link":"javascript:;","id":"item-271807"}]
